

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.96645899 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.92083706 |
| 3 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.91408796 |
| 4 | locomotory exploration behavior (GO:0035641) | 3.87966402 |
| 5 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.83230111 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.67388017 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.58757353 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.54852926 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52359521 |
| 10 | cardiac myofibril assembly (GO:0055003) | 3.52313973 |
| 11 | positive regulation of synapse maturation (GO:0090129) | 3.52119668 |
| 12 | cell communication by electrical coupling (GO:0010644) | 3.49616679 |
| 13 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.49169920 |
| 14 | cellular response to epinephrine stimulus (GO:0071872) | 3.47626854 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 3.41335358 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.31965609 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.28385437 |
| 18 | cell communication involved in cardiac conduction (GO:0086065) | 3.26623654 |
| 19 | negative regulation of protein localization to cell surface (GO:2000009) | 3.25370882 |
| 20 | synaptic vesicle maturation (GO:0016188) | 3.25064704 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.24664223 |
| 22 | neuronal ion channel clustering (GO:0045161) | 3.24588934 |
| 23 | cerebellar granule cell differentiation (GO:0021707) | 3.21020103 |
| 24 | response to epinephrine (GO:0071871) | 3.17688068 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 3.16558791 |
| 26 | sarcomere organization (GO:0045214) | 3.15649225 |
| 27 | plasma membrane repair (GO:0001778) | 3.12040720 |
| 28 | vocalization behavior (GO:0071625) | 3.11120290 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.10831706 |
| 30 | semaphorin-plexin signaling pathway (GO:0071526) | 3.10241215 |
| 31 | myofibril assembly (GO:0030239) | 3.09935630 |
| 32 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.02092610 |
| 33 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.98908557 |
| 34 | transmission of nerve impulse (GO:0019226) | 2.95083740 |
| 35 | neuronal action potential propagation (GO:0019227) | 2.94109001 |
| 36 | dendritic spine morphogenesis (GO:0060997) | 2.93227366 |
| 37 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.91648903 |
| 38 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.91062867 |
| 39 | regulation of synapse maturation (GO:0090128) | 2.90833252 |
| 40 | membrane depolarization during action potential (GO:0086010) | 2.90269308 |
| 41 | establishment of nucleus localization (GO:0040023) | 2.89561590 |
| 42 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.89391015 |
| 43 | regulation of membrane repolarization (GO:0060306) | 2.88910340 |
| 44 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.88291932 |
| 45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.87529811 |
| 46 | detection of calcium ion (GO:0005513) | 2.85530699 |
| 47 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.84575350 |
| 48 | cardiac muscle contraction (GO:0060048) | 2.84511127 |
| 49 | ensheathment of neurons (GO:0007272) | 2.83540375 |
| 50 | axon ensheathment (GO:0008366) | 2.83540375 |
| 51 | myelination (GO:0042552) | 2.82980950 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 2.82810046 |
| 53 | layer formation in cerebral cortex (GO:0021819) | 2.81768312 |
| 54 | dendrite morphogenesis (GO:0048813) | 2.81400360 |
| 55 | regulation of ARF protein signal transduction (GO:0032012) | 2.81030554 |
| 56 | cellular response to catecholamine stimulus (GO:0071870) | 2.80772746 |
| 57 | cellular response to monoamine stimulus (GO:0071868) | 2.80772746 |
| 58 | regulation of actin filament-based movement (GO:1903115) | 2.79001952 |
| 59 | hemidesmosome assembly (GO:0031581) | 2.78753676 |
| 60 | cell migration in hindbrain (GO:0021535) | 2.78569657 |
| 61 | cell-substrate junction assembly (GO:0007044) | 2.76722100 |
| 62 | axon ensheathment in central nervous system (GO:0032291) | 2.76065055 |
| 63 | central nervous system myelination (GO:0022010) | 2.76065055 |
| 64 | positive regulation of action potential (GO:0045760) | 2.73942133 |
| 65 | peripheral nervous system axon ensheathment (GO:0032292) | 2.73927962 |
| 66 | myelination in peripheral nervous system (GO:0022011) | 2.73927962 |
| 67 | adherens junction assembly (GO:0034333) | 2.73212185 |
| 68 | glutamate secretion (GO:0014047) | 2.73143694 |
| 69 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.70538577 |
| 70 | neuron cell-cell adhesion (GO:0007158) | 2.68845666 |
| 71 | activation of protein kinase A activity (GO:0034199) | 2.66831809 |
| 72 | regulation of synapse structural plasticity (GO:0051823) | 2.66256692 |
| 73 | sodium ion export (GO:0071436) | 2.65933549 |
| 74 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.65929306 |
| 75 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.65929306 |
| 76 | cell-substrate adherens junction assembly (GO:0007045) | 2.65477255 |
| 77 | focal adhesion assembly (GO:0048041) | 2.65477255 |
| 78 | nerve growth factor signaling pathway (GO:0038180) | 2.65277434 |
| 79 | glutamate receptor signaling pathway (GO:0007215) | 2.62938726 |
| 80 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.62869687 |
| 81 | cardiac muscle hypertrophy (GO:0003300) | 2.62662373 |
| 82 | synaptic transmission, glutamatergic (GO:0035249) | 2.62350550 |
| 83 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.62218128 |
| 84 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.61235087 |
| 85 | neuromuscular junction development (GO:0007528) | 2.61072767 |
| 86 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.60603473 |
| 87 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.60181823 |
| 88 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.59442075 |
| 89 | adult heart development (GO:0007512) | 2.58748920 |
| 90 | L-amino acid import (GO:0043092) | 2.57474201 |
| 91 | response to monoamine (GO:0071867) | 2.57376341 |
| 92 | response to catecholamine (GO:0071869) | 2.57376341 |
| 93 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.56288736 |
| 94 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.55948597 |
| 95 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.54809596 |
| 96 | multicellular organismal signaling (GO:0035637) | 2.54441961 |
| 97 | cellular sodium ion homeostasis (GO:0006883) | 2.54318247 |
| 98 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.53256675 |
| 99 | presynaptic membrane assembly (GO:0097105) | 2.52939371 |
| 100 | protein localization to synapse (GO:0035418) | 2.52864326 |
| 101 | synaptic vesicle exocytosis (GO:0016079) | 2.52326207 |
| 102 | adult walking behavior (GO:0007628) | 2.52221667 |
| 103 | positive regulation of sodium ion transport (GO:0010765) | 2.51310080 |
| 104 | amino acid import (GO:0043090) | 2.51039618 |
| 105 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.50974630 |
| 106 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.50892776 |
| 107 | potassium ion import (GO:0010107) | 2.50710723 |
| 108 | carnitine shuttle (GO:0006853) | 2.50579524 |
| 109 | striated muscle hypertrophy (GO:0014897) | 2.50409087 |
| 110 | exploration behavior (GO:0035640) | 2.49769825 |
| 111 | neuron recognition (GO:0008038) | 2.48997651 |
| 112 | membrane tubulation (GO:0097320) | 2.48659468 |
| 113 | neuromuscular process controlling balance (GO:0050885) | 2.46898433 |
| 114 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.45056386 |
| 115 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.43278072 |
| 116 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.42434829 |
| 117 | postsynaptic membrane organization (GO:0001941) | 2.42255695 |
| 118 | regulation of the force of heart contraction (GO:0002026) | 2.38851830 |
| 119 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.37629654 |
| 120 | neurotransmitter secretion (GO:0007269) | 2.34832482 |
| 121 | relaxation of cardiac muscle (GO:0055119) | 2.31756961 |
| 122 | dendritic spine organization (GO:0097061) | 2.30477752 |
| 123 | auditory behavior (GO:0031223) | 2.29821939 |
| 124 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.29021347 |
| 125 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.28960517 |
| 126 | cell volume homeostasis (GO:0006884) | 2.28432691 |
| 127 | negative regulation of myotube differentiation (GO:0010832) | 2.26026121 |
| 128 | potassium ion homeostasis (GO:0055075) | 2.23497793 |
| 129 | lung epithelium development (GO:0060428) | 2.22681684 |
| 130 | cardiac conduction (GO:0061337) | 2.21605288 |
| 131 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.21327454 |
| 132 | cardiac muscle adaptation (GO:0014887) | 2.20877142 |
| 133 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.20877142 |
| 134 | muscle hypertrophy in response to stress (GO:0003299) | 2.20877142 |
| 135 | positive regulation of dendrite development (GO:1900006) | 2.20096638 |
| 136 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.19091707 |
| 137 | neural tube development (GO:0021915) | 2.19028043 |
| 138 | protein targeting to plasma membrane (GO:0072661) | 2.17928722 |
| 139 | camera-type eye morphogenesis (GO:0048593) | 2.17578116 |
| 140 | desmosome organization (GO:0002934) | 2.17334275 |
| 141 | cell-cell junction maintenance (GO:0045217) | 2.17000727 |
| 142 | negative regulation of catenin import into nucleus (GO:0035414) | 2.16120861 |
| 143 | actomyosin structure organization (GO:0031032) | 2.15308010 |
| 144 | regulation of ARF GTPase activity (GO:0032312) | 2.14329710 |
| 145 | cell junction maintenance (GO:0034331) | 2.13689997 |
| 146 | negative regulation of fatty acid transport (GO:2000192) | 2.11429456 |
| 147 | regulation of sodium ion transport (GO:0002028) | 2.11176388 |
| 148 | metanephric nephron tubule development (GO:0072234) | 2.10325957 |
| 149 | metanephric tubule development (GO:0072170) | 2.10325957 |
| 150 | regulation of hippo signaling (GO:0035330) | 2.08802560 |
| 151 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.08758277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.01028858 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.64586016 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.59717577 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34895440 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.31753137 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.20867527 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.15749139 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.15749139 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05991109 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.00551537 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.98765789 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95663086 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93891101 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93161957 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.90520155 |
| 16 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.89140850 |
| 17 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88446007 |
| 18 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86880284 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85536390 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.82974184 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82577104 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82096432 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.77746299 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.77301299 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73433124 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.73198752 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.72705850 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69296531 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66871910 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65708237 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64388741 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62737673 |
| 33 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.53121861 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53033843 |
| 35 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46118683 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45831940 |
| 37 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44420219 |
| 38 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.44285181 |
| 39 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.43694665 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43559309 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43050981 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.42025205 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41124222 |
| 44 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.40706107 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39652248 |
| 46 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38934259 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38812472 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37670103 |
| 49 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36837159 |
| 50 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.34010738 |
| 51 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32990706 |
| 52 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.31946622 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31353914 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30352741 |
| 55 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30185327 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29970947 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29517451 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28612919 |
| 59 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27657525 |
| 60 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.27271773 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26580056 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25453512 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25218132 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23777619 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22375470 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.21847095 |
| 67 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21827143 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21800909 |
| 69 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.21703948 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21391548 |
| 71 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20863915 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20294966 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18982687 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16996054 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16828303 |
| 76 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.16815076 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15475590 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14718345 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14296929 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14263594 |
| 81 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13566518 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13466297 |
| 83 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13430966 |
| 84 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13068022 |
| 85 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12955127 |
| 86 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12399097 |
| 87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12209842 |
| 88 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11971002 |
| 89 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11971002 |
| 90 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11640512 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10332660 |
| 92 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10230402 |
| 93 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09795979 |
| 94 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.09793042 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09663632 |
| 96 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.09027437 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08798496 |
| 98 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08736925 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07964747 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07610676 |
| 101 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07289832 |
| 102 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07171364 |
| 103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06841671 |
| 104 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.03919690 |
| 105 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03880138 |
| 106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03419025 |
| 107 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.02807463 |
| 108 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02776581 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02484092 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02478895 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02434365 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02327038 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02056049 |
| 114 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00991860 |
| 115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00950151 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00887444 |
| 117 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00742491 |
| 118 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00061851 |
| 119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00061851 |
| 120 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00013580 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98125475 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97407366 |
| 123 | TBL1_22424771_ChIP-Seq_293T_Human | 0.97046374 |
| 124 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.96839092 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94939145 |
| 126 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94698058 |
| 127 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.94385374 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94224532 |
| 129 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.93644683 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93588292 |
| 131 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93358369 |
| 132 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91110845 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90986631 |
| 134 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90953036 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89953835 |
| 136 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87303279 |
| 137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86830609 |
| 138 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86796831 |
| 139 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85709711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.07414747 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.66195894 |
| 3 | MP0000751_myopathy | 3.46228818 |
| 4 | MP0004270_analgesia | 2.78871285 |
| 5 | MP0004215_abnormal_myocardial_fiber | 2.78804904 |
| 6 | MP0004084_abnormal_cardiac_muscle | 2.72862169 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.69452137 |
| 8 | MP0009046_muscle_twitch | 2.62604179 |
| 9 | MP0003880_abnormal_central_pattern | 2.62125836 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.49818498 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.46692444 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.37582150 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.04952777 |
| 14 | MP0001486_abnormal_startle_reflex | 2.01850887 |
| 15 | MP0003646_muscle_fatigue | 2.01728542 |
| 16 | MP0002064_seizures | 2.01355967 |
| 17 | MP0000749_muscle_degeneration | 1.97096267 |
| 18 | MP0009745_abnormal_behavioral_response | 1.95669242 |
| 19 | MP0002272_abnormal_nervous_system | 1.93245320 |
| 20 | MP0001348_abnormal_lacrimal_gland | 1.90540300 |
| 21 | MP0005330_cardiomyopathy | 1.86508680 |
| 22 | MP0003879_abnormal_hair_cell | 1.84718990 |
| 23 | MP0004087_abnormal_muscle_fiber | 1.81094510 |
| 24 | MP0002063_abnormal_learning/memory/cond | 1.80980871 |
| 25 | MP0004510_myositis | 1.74713314 |
| 26 | MP0000920_abnormal_myelination | 1.73919048 |
| 27 | MP0008775_abnormal_heart_ventricle | 1.72560503 |
| 28 | MP0004130_abnormal_muscle_cell | 1.71727265 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.66845787 |
| 30 | MP0000579_abnormal_nail_morphology | 1.64181281 |
| 31 | MP0002249_abnormal_larynx_morphology | 1.62463132 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.62369142 |
| 33 | MP0005620_abnormal_muscle_contractility | 1.61591973 |
| 34 | MP0004885_abnormal_endolymph | 1.59171189 |
| 35 | MP0000747_muscle_weakness | 1.57777872 |
| 36 | MP0004085_abnormal_heartbeat | 1.56277910 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.55986857 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.55328707 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.54740562 |
| 40 | MP0006138_congestive_heart_failure | 1.53612668 |
| 41 | MP0002972_abnormal_cardiac_muscle | 1.52862780 |
| 42 | MP0000778_abnormal_nervous_system | 1.52604701 |
| 43 | MP0005171_absent_coat_pigmentation | 1.51830791 |
| 44 | MP0008569_lethality_at_weaning | 1.51463267 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.51374736 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.49452141 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.43608915 |
| 48 | MP0002106_abnormal_muscle_physiology | 1.41636883 |
| 49 | MP0002269_muscular_atrophy | 1.41108406 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.40682339 |
| 51 | MP0005670_abnormal_white_adipose | 1.40587513 |
| 52 | MP0000733_abnormal_muscle_development | 1.38759746 |
| 53 | MP0003091_abnormal_cell_migration | 1.37812261 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.36538797 |
| 55 | MP0003690_abnormal_glial_cell | 1.36192447 |
| 56 | MP0003329_amyloid_beta_deposits | 1.35220095 |
| 57 | MP0004924_abnormal_behavior | 1.34039034 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.34039034 |
| 59 | MP0003045_fibrosis | 1.32994171 |
| 60 | MP0010630_abnormal_cardiac_muscle | 1.29376614 |
| 61 | MP0005369_muscle_phenotype | 1.27406058 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.26578145 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.24872419 |
| 64 | MP0000003_abnormal_adipose_tissue | 1.24147120 |
| 65 | MP0004233_abnormal_muscle_weight | 1.23700031 |
| 66 | MP0005257_abnormal_intraocular_pressure | 1.23692159 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.22929101 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.22027087 |
| 69 | MP0004484_altered_response_of | 1.21487259 |
| 70 | MP0001968_abnormal_touch/_nociception | 1.20525079 |
| 71 | MP0003279_aneurysm | 1.19463629 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.17632667 |
| 73 | MP0000534_abnormal_ureter_morphology | 1.17221051 |
| 74 | MP0005410_abnormal_fertilization | 1.15989637 |
| 75 | MP0000955_abnormal_spinal_cord | 1.15148229 |
| 76 | MP0002089_abnormal_postnatal_growth/wei | 1.14687294 |
| 77 | MP0005385_cardiovascular_system_phenoty | 1.14243166 |
| 78 | MP0001544_abnormal_cardiovascular_syste | 1.14243166 |
| 79 | MP0001485_abnormal_pinna_reflex | 1.13594812 |
| 80 | MP0000537_abnormal_urethra_morphology | 1.12848191 |
| 81 | MP0004185_abnormal_adipocyte_glucose | 1.11917241 |
| 82 | MP0002184_abnormal_innervation | 1.11737119 |
| 83 | MP0001958_emphysema | 1.11491303 |
| 84 | MP0001849_ear_inflammation | 1.10861654 |
| 85 | MP0002735_abnormal_chemical_nociception | 1.10012875 |
| 86 | MP0010368_abnormal_lymphatic_system | 1.09995371 |
| 87 | MP0003950_abnormal_plasma_membrane | 1.09064743 |
| 88 | MP0002882_abnormal_neuron_morphology | 1.08606868 |
| 89 | MP0000750_abnormal_muscle_regeneration | 1.08214460 |
| 90 | MP0002108_abnormal_muscle_morphology | 1.08016612 |
| 91 | MP0003634_abnormal_glial_cell | 1.07726271 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 1.07569155 |
| 93 | MP0002733_abnormal_thermal_nociception | 1.06262465 |
| 94 | MP0004043_abnormal_pH_regulation | 1.06054550 |
| 95 | MP0003632_abnormal_nervous_system | 1.05284127 |
| 96 | MP0004742_abnormal_vestibular_system | 1.04000098 |
| 97 | MP0001501_abnormal_sleep_pattern | 1.03772823 |
| 98 | MP0005503_abnormal_tendon_morphology | 1.03062788 |
| 99 | MP0001299_abnormal_eye_distance/ | 1.02752864 |
| 100 | MP0001970_abnormal_pain_threshold | 1.02515190 |
| 101 | MP0002822_catalepsy | 1.01172218 |
| 102 | MP0000566_synostosis | 1.00550350 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.98273617 |
| 104 | MP0003787_abnormal_imprinting | 0.98102749 |
| 105 | MP0002909_abnormal_adrenal_gland | 0.96547030 |
| 106 | MP0004147_increased_porphyrin_level | 0.95618754 |
| 107 | MP0004272_abnormal_basement_membrane | 0.95405441 |
| 108 | MP0004811_abnormal_neuron_physiology | 0.93835178 |
| 109 | MP0004858_abnormal_nervous_system | 0.92005147 |
| 110 | MP0003631_nervous_system_phenotype | 0.91068040 |
| 111 | MP0002229_neurodegeneration | 0.90705667 |
| 112 | MP0003633_abnormal_nervous_system | 0.89434975 |
| 113 | MP0001984_abnormal_olfaction | 0.86856310 |
| 114 | MP0002152_abnormal_brain_morphology | 0.84514974 |
| 115 | MP0003283_abnormal_digestive_organ | 0.83342173 |
| 116 | MP0002557_abnormal_social/conspecific_i | 0.83119274 |
| 117 | MP0005023_abnormal_wound_healing | 0.81489431 |
| 118 | MP0001661_extended_life_span | 0.81108638 |
| 119 | MP0004142_abnormal_muscle_tone | 0.80585208 |
| 120 | MP0002168_other_aberrant_phenotype | 0.80352522 |
| 121 | MP0001270_distended_abdomen | 0.78075219 |
| 122 | MP0000762_abnormal_tongue_morphology | 0.76394605 |
| 123 | MP0002127_abnormal_cardiovascular_syste | 0.75211476 |
| 124 | MP0005360_urolithiasis | 0.75071253 |
| 125 | MP0008438_abnormal_cutaneous_collagen | 0.68688369 |
| 126 | MP0005187_abnormal_penis_morphology | 0.68056813 |
| 127 | MP0000462_abnormal_digestive_system | 0.65726437 |
| 128 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65144901 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.64441570 |
| 130 | MP0005409_darkened_coat_color | 0.63127545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.26236711 |
| 2 | Obstructive sleep apnea (HP:0002870) | 4.14539425 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 3.95566788 |
| 4 | Muscle fiber splitting (HP:0003555) | 3.58739962 |
| 5 | Action tremor (HP:0002345) | 3.55127823 |
| 6 | Bundle branch block (HP:0011710) | 3.53154282 |
| 7 | Syncope (HP:0001279) | 3.50907689 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.49675500 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 3.48435178 |
| 10 | Atrial fibrillation (HP:0005110) | 3.47669414 |
| 11 | Prolonged QT interval (HP:0001657) | 3.46120926 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.40967046 |
| 13 | Difficulty running (HP:0009046) | 3.38183515 |
| 14 | Myokymia (HP:0002411) | 3.34780541 |
| 15 | Focal seizures (HP:0007359) | 3.32026042 |
| 16 | Primary atrial arrhythmia (HP:0001692) | 3.25195013 |
| 17 | Focal motor seizures (HP:0011153) | 3.24403502 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 3.22774262 |
| 19 | Ventricular fibrillation (HP:0001663) | 3.05858457 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 3.01219897 |
| 21 | Cerebral aneurysm (HP:0004944) | 3.00743793 |
| 22 | Supraventricular tachycardia (HP:0004755) | 2.99574932 |
| 23 | Hyperacusis (HP:0010780) | 2.97117093 |
| 24 | Broad face (HP:0000283) | 2.96584404 |
| 25 | Supraventricular arrhythmia (HP:0005115) | 2.96534880 |
| 26 | Dysmetric saccades (HP:0000641) | 2.96011203 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 2.91179838 |
| 28 | Ventricular tachycardia (HP:0004756) | 2.90398086 |
| 29 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.89288763 |
| 30 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.89288763 |
| 31 | Shallow orbits (HP:0000586) | 2.84899897 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.83088117 |
| 33 | Atonic seizures (HP:0010819) | 2.77296406 |
| 34 | Insidious onset (HP:0003587) | 2.76073198 |
| 35 | Termporal pattern (HP:0011008) | 2.76073198 |
| 36 | Dysmetria (HP:0001310) | 2.75362171 |
| 37 | Febrile seizures (HP:0002373) | 2.74196226 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.74184518 |
| 39 | Sensory axonal neuropathy (HP:0003390) | 2.72300102 |
| 40 | Ventricular arrhythmia (HP:0004308) | 2.65891395 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.65156597 |
| 42 | Intention tremor (HP:0002080) | 2.64834434 |
| 43 | Ulnar bowing (HP:0003031) | 2.63146400 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.62924073 |
| 45 | Abnormal EKG (HP:0003115) | 2.62286422 |
| 46 | Bronchomalacia (HP:0002780) | 2.61333865 |
| 47 | Spastic gait (HP:0002064) | 2.58408227 |
| 48 | Heart block (HP:0012722) | 2.51887696 |
| 49 | Scanning speech (HP:0002168) | 2.48975524 |
| 50 | Epileptic encephalopathy (HP:0200134) | 2.45521506 |
| 51 | Myotonia (HP:0002486) | 2.43204127 |
| 52 | Supranuclear gaze palsy (HP:0000605) | 2.43078130 |
| 53 | Genetic anticipation (HP:0003743) | 2.42404763 |
| 54 | Onion bulb formation (HP:0003383) | 2.40997035 |
| 55 | Broad-based gait (HP:0002136) | 2.40642292 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.40024538 |
| 57 | Upper limb amyotrophy (HP:0009129) | 2.40024538 |
| 58 | EMG: myopathic abnormalities (HP:0003458) | 2.38900398 |
| 59 | Lipoatrophy (HP:0100578) | 2.37381626 |
| 60 | Exercise-induced muscle cramps (HP:0003710) | 2.37182170 |
| 61 | Stridor (HP:0010307) | 2.34287520 |
| 62 | Neurofibrillary tangles (HP:0002185) | 2.33281786 |
| 63 | Subaortic stenosis (HP:0001682) | 2.30716031 |
| 64 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.30716031 |
| 65 | Impaired social interactions (HP:0000735) | 2.27840399 |
| 66 | Abnormal social behavior (HP:0012433) | 2.27840399 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.27452999 |
| 68 | Atrioventricular block (HP:0001678) | 2.27293922 |
| 69 | Lower limb muscle weakness (HP:0007340) | 2.26941848 |
| 70 | Cerebral inclusion bodies (HP:0100314) | 2.24191938 |
| 71 | Pheochromocytoma (HP:0002666) | 2.23240394 |
| 72 | Visual hallucinations (HP:0002367) | 2.23032915 |
| 73 | Atrophic scars (HP:0001075) | 2.22887508 |
| 74 | Protrusio acetabuli (HP:0003179) | 2.22848340 |
| 75 | Hypoplasia of the iris (HP:0007676) | 2.22404358 |
| 76 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.19809100 |
| 77 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18846098 |
| 78 | Poor eye contact (HP:0000817) | 2.18805904 |
| 79 | Distal lower limb amyotrophy (HP:0008944) | 2.18407203 |
| 80 | Ankle clonus (HP:0011448) | 2.17058067 |
| 81 | Lower limb amyotrophy (HP:0007210) | 2.15449501 |
| 82 | Steppage gait (HP:0003376) | 2.15215311 |
| 83 | Abnormality of the fingertips (HP:0001211) | 2.09530008 |
| 84 | Increased connective tissue (HP:0009025) | 2.09283252 |
| 85 | Postural instability (HP:0002172) | 2.08649281 |
| 86 | Broad metatarsal (HP:0001783) | 2.08052215 |
| 87 | Urinary urgency (HP:0000012) | 2.07525215 |
| 88 | Alacrima (HP:0000522) | 2.07227808 |
| 89 | Scapular winging (HP:0003691) | 2.06974534 |
| 90 | Dilated cardiomyopathy (HP:0001644) | 2.00175583 |
| 91 | Hypoplastic ischia (HP:0003175) | 1.98581665 |
| 92 | Generalized tonic-clonic seizures (HP:0002069) | 1.98569611 |
| 93 | Hammertoe (HP:0001765) | 1.98115040 |
| 94 | Foot dorsiflexor weakness (HP:0009027) | 1.96464006 |
| 95 | Hypopigmentation of the fundus (HP:0007894) | 1.96019263 |
| 96 | Abnormality of the foot musculature (HP:0001436) | 1.95710787 |
| 97 | Hemiplegia (HP:0002301) | 1.94003837 |
| 98 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93470682 |
| 99 | Aplasia involving bones of the extremities (HP:0009825) | 1.92031701 |
| 100 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.92031701 |
| 101 | Aplasia of the phalanges of the hand (HP:0009802) | 1.92031701 |
| 102 | Hemiparesis (HP:0001269) | 1.91603461 |
| 103 | Insomnia (HP:0100785) | 1.89816526 |
| 104 | Type 1 muscle fiber predominance (HP:0003803) | 1.89071523 |
| 105 | Heterotopia (HP:0002282) | 1.88747654 |
| 106 | Hyperkalemia (HP:0002153) | 1.87822381 |
| 107 | Myoglobinuria (HP:0002913) | 1.87166542 |
| 108 | Laryngomalacia (HP:0001601) | 1.86977726 |
| 109 | Truncal ataxia (HP:0002078) | 1.86605068 |
| 110 | Turricephaly (HP:0000262) | 1.86231465 |
| 111 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.86214976 |
| 112 | Neoplasm of the heart (HP:0100544) | 1.84604434 |
| 113 | Urethral obstruction (HP:0000796) | 1.84165952 |
| 114 | Flat acetabular roof (HP:0003180) | 1.84034749 |
| 115 | Bell-shaped thorax (HP:0001591) | 1.83223175 |
| 116 | Vertebral arch anomaly (HP:0008438) | 1.82577230 |
| 117 | Aortic aneurysm (HP:0004942) | 1.82175827 |
| 118 | Renovascular hypertension (HP:0100817) | 1.81949884 |
| 119 | Diplopia (HP:0000651) | 1.81902741 |
| 120 | Abnormality of binocular vision (HP:0011514) | 1.81902741 |
| 121 | Blue irides (HP:0000635) | 1.81784255 |
| 122 | Limited hip movement (HP:0008800) | 1.80875259 |
| 123 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.79162072 |
| 124 | Drooling (HP:0002307) | 1.78273978 |
| 125 | Excessive salivation (HP:0003781) | 1.78273978 |
| 126 | Hyperventilation (HP:0002883) | 1.78029119 |
| 127 | Hand muscle atrophy (HP:0009130) | 1.77546941 |
| 128 | Absence seizures (HP:0002121) | 1.76856811 |
| 129 | Depression (HP:0000716) | 1.76026015 |
| 130 | Macroorchidism (HP:0000053) | 1.75077581 |
| 131 | Pointed chin (HP:0000307) | 1.74839389 |
| 132 | EMG: neuropathic changes (HP:0003445) | 1.74661261 |
| 133 | Dislocated radial head (HP:0003083) | 1.74213557 |
| 134 | Aneurysm (HP:0002617) | 1.73873036 |
| 135 | Fragile skin (HP:0001030) | 1.72956054 |
| 136 | Slow progression (HP:0003677) | 1.72655659 |
| 137 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.71857071 |
| 138 | Neonatal short-limb short stature (HP:0008921) | 1.71741032 |
| 139 | Difficulty climbing stairs (HP:0003551) | 1.71652650 |
| 140 | Abnormality of the ischium (HP:0003174) | 1.71564019 |
| 141 | Sleep apnea (HP:0010535) | 1.70754835 |
| 142 | Gowers sign (HP:0003391) | 1.69548325 |
| 143 | Tracheomalacia (HP:0002779) | 1.69197848 |
| 144 | Long eyelashes (HP:0000527) | 1.68428219 |
| 145 | Distal lower limb muscle weakness (HP:0009053) | 1.67650568 |
| 146 | Impaired smooth pursuit (HP:0007772) | 1.65392759 |
| 147 | Bradycardia (HP:0001662) | 1.64329561 |
| 148 | Akinesia (HP:0002304) | 1.64211956 |
| 149 | Abnormality of the radial head (HP:0003995) | 1.64079732 |
| 150 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.61898265 |
| 151 | Germ cell neoplasia (HP:0100728) | 1.58824413 |
| 152 | Wormian bones (HP:0002645) | 1.58082823 |
| 153 | Long toe (HP:0010511) | 1.56387507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 2.76681194 |
| 2 | STK39 | 2.66667405 |
| 3 | TNIK | 2.61637260 |
| 4 | EEF2K | 2.44141266 |
| 5 | NTRK3 | 2.40169701 |
| 6 | EPHA4 | 2.31195212 |
| 7 | PHKG1 | 2.20190280 |
| 8 | PHKG2 | 2.20190280 |
| 9 | OBSCN | 2.14588572 |
| 10 | PAK6 | 2.10010652 |
| 11 | MAP3K9 | 1.97455286 |
| 12 | CAMK1G | 1.96078456 |
| 13 | PRKD3 | 1.88333981 |
| 14 | WNK1 | 1.87458599 |
| 15 | MAP3K4 | 1.85561078 |
| 16 | DMPK | 1.83506507 |
| 17 | MARK1 | 1.80273293 |
| 18 | TYRO3 | 1.75586808 |
| 19 | PKN2 | 1.68473306 |
| 20 | EPHB1 | 1.68259659 |
| 21 | PKN1 | 1.59563990 |
| 22 | LMTK2 | 1.58902679 |
| 23 | OXSR1 | 1.58115234 |
| 24 | NTRK2 | 1.56325462 |
| 25 | TTN | 1.53968037 |
| 26 | PAK3 | 1.52583064 |
| 27 | MST1R | 1.47754577 |
| 28 | WNK4 | 1.47320128 |
| 29 | INSRR | 1.41098046 |
| 30 | NTRK1 | 1.39839051 |
| 31 | PNCK | 1.37033844 |
| 32 | FGFR2 | 1.30674007 |
| 33 | CAMK1D | 1.30564304 |
| 34 | BCR | 1.26336490 |
| 35 | DAPK2 | 1.25501057 |
| 36 | STK38 | 1.23722267 |
| 37 | RIPK1 | 1.22868641 |
| 38 | UHMK1 | 1.19910400 |
| 39 | EPHA2 | 1.19092812 |
| 40 | PDK4 | 1.18295644 |
| 41 | PDK3 | 1.18295644 |
| 42 | PRPF4B | 1.17071989 |
| 43 | SMG1 | 1.14961889 |
| 44 | CDC42BPA | 1.11529650 |
| 45 | MAPK12 | 1.10815622 |
| 46 | MARK2 | 1.10628655 |
| 47 | CDK5 | 1.08056963 |
| 48 | PTK2B | 1.07778051 |
| 49 | MAPK13 | 1.05186087 |
| 50 | CAMK2D | 1.04389812 |
| 51 | SGK494 | 1.03355769 |
| 52 | SGK223 | 1.03355769 |
| 53 | STK11 | 1.02730806 |
| 54 | KSR2 | 1.01058192 |
| 55 | FGFR4 | 0.99566666 |
| 56 | MINK1 | 0.98478509 |
| 57 | TRPM7 | 0.97468808 |
| 58 | RPS6KA2 | 0.97366154 |
| 59 | RET | 0.96940859 |
| 60 | MAPK11 | 0.94249517 |
| 61 | MAP2K4 | 0.91715428 |
| 62 | PRKAA2 | 0.91395631 |
| 63 | CASK | 0.89831984 |
| 64 | MAPKAPK3 | 0.89606525 |
| 65 | SGK1 | 0.89181695 |
| 66 | ROCK2 | 0.84814878 |
| 67 | MET | 0.83747846 |
| 68 | PRKD2 | 0.82884264 |
| 69 | CAMK2A | 0.82234927 |
| 70 | BRD4 | 0.82032154 |
| 71 | ROCK1 | 0.81219700 |
| 72 | MAP3K7 | 0.80033641 |
| 73 | SIK2 | 0.79784263 |
| 74 | PRKAA1 | 0.78925747 |
| 75 | PRKD1 | 0.78564823 |
| 76 | PAK2 | 0.78555352 |
| 77 | SGK3 | 0.76715994 |
| 78 | PDPK1 | 0.75603444 |
| 79 | MAPK10 | 0.75324459 |
| 80 | PDGFRA | 0.74528927 |
| 81 | PIK3CA | 0.74497670 |
| 82 | GRK5 | 0.71384336 |
| 83 | MUSK | 0.70360469 |
| 84 | ERN1 | 0.70165616 |
| 85 | SIK1 | 0.70108188 |
| 86 | CAMKK1 | 0.69677726 |
| 87 | CAMK1 | 0.69384371 |
| 88 | ERBB2 | 0.68388226 |
| 89 | PRKCH | 0.68278561 |
| 90 | MAP3K6 | 0.68024409 |
| 91 | MYLK | 0.67705507 |
| 92 | CAMK2B | 0.67668496 |
| 93 | TAOK1 | 0.66771950 |
| 94 | SGK2 | 0.66384271 |
| 95 | CAMK4 | 0.63717022 |
| 96 | LATS1 | 0.63407211 |
| 97 | NEK6 | 0.62902635 |
| 98 | LATS2 | 0.61915459 |
| 99 | PTK2 | 0.61315473 |
| 100 | BMX | 0.61149953 |
| 101 | PINK1 | 0.60962409 |
| 102 | AKT3 | 0.60375682 |
| 103 | MAP2K7 | 0.60366219 |
| 104 | ALK | 0.60044809 |
| 105 | KSR1 | 0.58664880 |
| 106 | TRIB3 | 0.58261120 |
| 107 | PDGFRB | 0.58163186 |
| 108 | RPS6KA3 | 0.56975960 |
| 109 | MAP2K6 | 0.56663998 |
| 110 | MAP3K10 | 0.56640475 |
| 111 | PDK1 | 0.56137121 |
| 112 | CDK12 | 0.55678649 |
| 113 | CSNK1A1L | 0.55581962 |
| 114 | MAP3K2 | 0.55109910 |
| 115 | PRKCE | 0.53064022 |
| 116 | CAMK2G | 0.52870558 |
| 117 | FRK | 0.52199189 |
| 118 | MAP2K1 | 0.52166764 |
| 119 | DDR2 | 0.51485352 |
| 120 | CDK19 | 0.50777118 |
| 121 | DYRK1A | 0.50507551 |
| 122 | FER | 0.50034049 |
| 123 | MAP3K13 | 0.48486762 |
| 124 | MELK | 0.48223941 |
| 125 | MTOR | 0.47501347 |
| 126 | PTK6 | 0.47311789 |
| 127 | MAPK15 | 0.46599940 |
| 128 | PRKCZ | 0.46361862 |
| 129 | FGFR3 | 0.43569327 |
| 130 | MAPK8 | 0.43125796 |
| 131 | MAPK7 | 0.42154133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.23901028 |
| 2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.03058575 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.02537343 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.00646275 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.97615339 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.92688179 |
| 7 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.89064832 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.81970064 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.75094390 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.74444529 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.72892555 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.69308589 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.68509719 |
| 14 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.61882152 |
| 15 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.61462927 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.60567936 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.53008477 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.52567104 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49282212 |
| 20 | Axon guidance_Homo sapiens_hsa04360 | 1.49134101 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49100560 |
| 22 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.48982831 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.48432700 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47487507 |
| 25 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.43778761 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43111805 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43031398 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.41976972 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.40399786 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35943383 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.35411697 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28741606 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27098866 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.24835570 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22225528 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19179511 |
| 37 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17033330 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13796252 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.12927208 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09274400 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09014363 |
| 42 | Adherens junction_Homo sapiens_hsa04520 | 1.08573991 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.06532691 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05968933 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02442708 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.02049935 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01624355 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00876425 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.00857027 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00479214 |
| 51 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99457081 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99394366 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98131193 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96587166 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95416118 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.94542122 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93877660 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91788554 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91787771 |
| 60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90227692 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.89111548 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.86534996 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86504002 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86036162 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85647715 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84766228 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84188598 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83434413 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81174755 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80271624 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79573648 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79000667 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78875557 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78841669 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.78383834 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78161961 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77492794 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77300128 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.76702586 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76673213 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.75184065 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73868514 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71545503 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70468160 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.69777569 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69253241 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68568114 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67929855 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64541135 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63823328 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.63072646 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62860470 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62719350 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62558133 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.62421011 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62082957 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61418908 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61345747 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61024850 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.60953538 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60021471 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59894096 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.59708991 |
| 104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58290480 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56877002 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55092963 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.53864655 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53826485 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53645877 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.53377365 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52555753 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51533979 |
| 113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51518223 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50510203 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49906330 |
| 116 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49309673 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49104690 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47403856 |
| 119 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47287588 |
| 120 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46054648 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45380023 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45195580 |
| 123 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44373458 |

